Q2 2024 Financial Results and Business Update August 7, 2024 2 Today's Agenda Sections Presenter(s) Opening Remarks Saqib Islam Chief Executive Officer OGSIVEO for Desmoid Tumors Bhavesh Ashar Chief Commercial Officer Mirdametinib for NF1-PN Jim Cassidy, MD, PhD Chief Medical Officer Financial Results Frank Perier, Jr. Chief Financial Officer Looking Ahead Saqib Islam Chief Executive Officer Q&A All Forward-Looking Statements 3 Note: Unless otherwise indicated, the information presented herein is as of Augu ...